학술논문

Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2-early breast cancer: Primary results from the phase III NATALEE trial.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JUN 10 2023, 41 17_SUPPL, pLBA500-pLBA500, 1p. Supplement: 17_
Subject
Language
English
ISSN
15277755